Precision Medicine In Action: Mindera Health and Liviniti Join Forces to Predict Biologic Response in PsO Patients
Mindera Health, developer of Mind.Px, is partnering with pharmacy benefit manager Liviniti to improve the management of moderate-to-severe psoriasis via precision medicine. Using a patented dermal biomarker patch, Mind.Px prospectively predicts a patient’s response to biologic drug classes prior to therapeutic selection and treatment. The patch captures more than 7,000 biomarkers per sample through a rapid […]